A detailed history of Marquette Asset Management, LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Marquette Asset Management, LLC holds 9,908 shares of FLGT stock, worth $199,448. This represents 0.03% of its overall portfolio holdings.

Number of Shares
9,908
Previous 8,717 13.66%
Holding current value
$199,448
Previous $171,000 25.73%
% of portfolio
0.03%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$19.6 - $25.06 $23,343 - $29,846
1,191 Added 13.66%
9,908 $215,000
Q2 2024

Aug 14, 2024

BUY
$19.09 - $22.57 $166,407 - $196,742
8,717 New
8,717 $171,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $609M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Marquette Asset Management, LLC Portfolio

Follow Marquette Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marquette Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marquette Asset Management, LLC with notifications on news.